Correlation Between Terns Pharmaceuticals and Biovie
Can any of the company-specific risk be diversified away by investing in both Terns Pharmaceuticals and Biovie at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Terns Pharmaceuticals and Biovie into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Terns Pharmaceuticals and Biovie Inc, you can compare the effects of market volatilities on Terns Pharmaceuticals and Biovie and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Terns Pharmaceuticals with a short position of Biovie. Check out your portfolio center. Please also check ongoing floating volatility patterns of Terns Pharmaceuticals and Biovie.
Diversification Opportunities for Terns Pharmaceuticals and Biovie
0.55 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Terns and Biovie is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding Terns Pharmaceuticals and Biovie Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biovie Inc and Terns Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Terns Pharmaceuticals are associated (or correlated) with Biovie. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biovie Inc has no effect on the direction of Terns Pharmaceuticals i.e., Terns Pharmaceuticals and Biovie go up and down completely randomly.
Pair Corralation between Terns Pharmaceuticals and Biovie
Given the investment horizon of 90 days Terns Pharmaceuticals is expected to generate 0.72 times more return on investment than Biovie. However, Terns Pharmaceuticals is 1.4 times less risky than Biovie. It trades about -0.23 of its potential returns per unit of risk. Biovie Inc is currently generating about -0.19 per unit of risk. If you would invest 553.00 in Terns Pharmaceuticals on December 28, 2024 and sell it today you would lose (241.00) from holding Terns Pharmaceuticals or give up 43.58% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Terns Pharmaceuticals vs. Biovie Inc
Performance |
Timeline |
Terns Pharmaceuticals |
Biovie Inc |
Terns Pharmaceuticals and Biovie Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Terns Pharmaceuticals and Biovie
The main advantage of trading using opposite Terns Pharmaceuticals and Biovie positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Terns Pharmaceuticals position performs unexpectedly, Biovie can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biovie will offset losses from the drop in Biovie's long position.Terns Pharmaceuticals vs. Amylyx Pharmaceuticals | Terns Pharmaceuticals vs. Acumen Pharmaceuticals | Terns Pharmaceuticals vs. Inozyme Pharma | Terns Pharmaceuticals vs. X4 Pharmaceuticals |
Biovie vs. Inozyme Pharma | Biovie vs. Day One Biopharmaceuticals | Biovie vs. Terns Pharmaceuticals | Biovie vs. Eledon Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Complementary Tools
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |